Pannier J, Nass N, Yaakoub MK, Stelzner FMM, Veit S, Kalomoiri M, Yassine M, Behre G. Monoclonal Antibody Therapy for COVID-19: A Retrospective Observational Study at a Regional Hospital. Infect Dis Rep. 2023 Feb 20;15(1):125-131. doi: 10.3390/idr15010013. PMID: 36826353; PMCID: PMC9956015.
Graf S, Haybaeck J, Behre G, Kalinski T, Nass N. The tamoxifen-regulated, long non-coding RNA LINC00992 affects proliferation, migration, and expression of tamoxifen resistance-associated genes in MCF-7 breast cancer cells. Contemp Oncol (Pozn). 2022;26(4):294-305. doi: 10.5114/wo.2023.125000. Epub 2022 Dec 30. PMID: 36816389; PMCID: PMC9933353.
Behringer A, Stoimenovski D, Porsch M, Hoffmann K, Behre G, Grosse I, Kalinski T, Haybaeck J, Nass N. Relationship of micro-RNA, mRNA and eIF Expression in Tamoxifen-Adapted MCF-7 Breast Cancer Cells: Impact of miR-1972 on Gene Expression, Proliferation and Migration. Biomolecules. 2022 Jun 29;12(7):916. doi: 10.3390/biom12070916.
Czapiewski P, Cornelius M, Hartig R, Kalinski T, Haybaeck J, Dittmer A, Dittmer J, Ignatov A, Nass N. BCL3 expression is strongly associated with the occurrence of breast cancer relapse under tamoxifen treatment in a retrospective cohort study. Virchows Arch. 2022 Mar;480(3):529-541. doi: 10.1007/s00428-021-03238-8.
Maiwald J-H, Sprung S, Czapiewski P, Lessel W, Scherping A, Schomburg D, Plaumann M, Tomasik B, Behre G, Haybaeck J, Ignatov A, Eggemann H, Nass N. The impact of G protein-coupled oestrogen receptor 1 on male breast cancer: a retrospective analysis. Contemp Oncol (Pozn) 2021; 25 (3): 204–212
Vo DK, Engler A, Stoimenovski D, Hartig R, Kaehne T, Kalinski T, Naumann M, Haybaeck J, Nass N. Interactome Mapping of eIF3A in a Colon Cancer and an Immortalized Embryonic Cell Line Using Proximity-Dependent Biotin Identification. Cancers (Basel). 2021 Mar 14;13(6):1293. doi: 10.3390/cancers13061293.
Vo DH, Hartig R, Weinert S, Haybaeck J, Nass N. G-Protein-Coupled Estrogen Receptor (GPER)-Specific Agonist G1 Induces ER Stress Leading to Cell Death in MCF-7 Cells. Biomolecules. 2019 Sep 18;9(9):503. doi: 10.3390/biom9090503
Pieper W, Ignatov A, Kalinski T, Haybaeck J, Czapiewski P, Nass N. The predictive potential of Neuronatin for neoadjuvant chemotherapy of breast cancer. Cancer Biomarkers, 2021, Cancer Biomark. 2021;32(2):161-173.
Scheifele C, Zhu Q, Ignatov A, Kalinski T, Nass N. Glyoxalase 1 expression analysis by immunohistochemistry in breast cancer. Pathol Res Pract. 2020 216;153257. doi:10.1016/j.prp.2020.153257. Epub 2020 Oct 18. PMID: 33142109
Porsch M, Özdemir E, Wisniewski M, Graf S, Bull F, Hoffmann K, Ignatov A, Haybaeck J, Grosse I, Kalinski T, Nass N. Time resolved gene expression analysis during tamoxifen adaption of MCF-7 cells identifies long non-coding RNAs with prognostic impact. RNA Biol. 2019 May;16(5):661-674. doi: 10.1080/15476286.2019.1581597
Eine vollständige Publikationsliste gibt es hier online von Prof. Dr. Thomas Kalinski und Dr. Norbert Nass.
